Thomas Jansson Selected Research

Protein Isoforms (Isoforms)

8/2015	Increased placental nutrient transport in a novel mouse model of maternal obesity with fetal overgrowth.
6/2015	Expression and functional characterisation of System L amino acid transporters in the human term placenta.
1/2013	Activation of placental mTOR signaling and amino acid transporters in obese women giving birth to large babies.
1/2009	High-fat diet before and during pregnancy causes marked up-regulation of placental nutrient transport and fetal overgrowth in C57/BL6 mice.
7/2007	Role of the placenta in fetal programming: underlying mechanisms and potential interventional approaches.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Thomas Jansson Research Topics

Disease

34	Fetal Growth Retardation (Intrauterine Growth Retardation) 01/2022 - 07/2006
19	Maternal Obesity 02/2024 - 01/2013
18	Obesity 01/2023 - 03/2007
15	Birth Weight (Birth Weights) 01/2023 - 03/2007
14	Insulin Resistance 01/2023 - 03/2007
10	Gestational Diabetes (Gestational Diabetes Mellitus) 01/2022 - 05/2010
9	Hypoxia (Hypoxemia) 01/2022 - 02/2016
8	Fetal Weight 11/2022 - 06/2007
7	Inflammation (Inflammations) 01/2022 - 10/2013
6	Placental Insufficiency 01/2020 - 08/2003
4	Metabolic Diseases (Metabolic Disease) 01/2022 - 07/2007
4	Neoplasms (Cancer) 11/2019 - 01/2017
3	Pregnancy Complications 11/2023 - 05/2010
3	Glucose Intolerance 11/2022 - 08/2015
3	Malnutrition (Nutritional Deficiencies) 01/2021 - 11/2006
3	Neural Tube Defects (Exencephaly) 01/2020 - 01/2017
3	Overweight 04/2016 - 10/2013
2	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 01/2018
2	Tuberous Sclerosis (Bourneville's Disease) 01/2021 - 02/2016
2	Infections 12/2020 - 08/2006
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2020 - 10/2015
2	Malaria 01/2017 - 01/2017
2	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 01/2016 - 11/2015
2	Body Weight (Weight, Body) 04/2013 - 12/2012
1	Hyperlipidemias (Hyperlipidemia) 01/2024
1	Fibrosis (Cirrhosis) 11/2022
1	Left Ventricular Dysfunction 01/2022
1	Fatty Liver 01/2022
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2022
1	Gestational Weight Gain 01/2021

Drug/Important Bio-Agent (IBA)

26	Insulin (Novolin)FDA Link 01/2023 - 11/2006
21	Amino Acids FDA Link 11/2023 - 11/2006
18	Proteins (Proteins, Gene)FDA Link 11/2022 - 11/2006
17	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 03/2005
11	Sirolimus (Rapamycin)FDA Link 01/2022 - 02/2016
11	Insulin-Like Growth Factor Binding Protein 1IBA 01/2022 - 06/2008
11	AdiponectinIBA 01/2022 - 05/2010
10	Insulin-Like Growth Factor I (IGF-1)IBA 10/2021 - 11/2006
10	Folic Acid (Vitamin M)FDA LinkGeneric 01/2021 - 07/2011
10	Amino Acid Transport Systems (Amino Acid Transporter)IBA 01/2020 - 11/2006
9	Mechanistic Target of Rapamycin Complex 1IBA 01/2021 - 10/2013
7	Fatty Acids (Saturated Fatty Acids)IBA 01/2024 - 12/2015
7	LeptinIBA 01/2021 - 11/2006
6	LipidsIBA 01/2022 - 12/2012
5	Triglycerides (Triacylglycerol)IBA 01/2023 - 12/2012
5	Insulin-Like PeptidesIBA 01/2022 - 01/2018
5	Protein Isoforms (Isoforms)IBA 08/2015 - 07/2007
4	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 01/2022 - 02/2015
4	Mechanistic Target of Rapamycin Complex 2IBA 01/2021 - 02/2016
4	Oxygen (Dioxygen)IBA 01/2021 - 02/2016
4	Hormones (Hormone)IBA 01/2020 - 03/2005
4	Leucine (L-Leucine)FDA Link 01/2020 - 09/2015
4	AndrogensIBA 01/2017 - 12/2012
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2022 - 01/2020
3	Insulin-Like Growth Factor Binding ProteinsIBA 10/2021 - 01/2020
3	Small Interfering RNA (siRNA)IBA 01/2021 - 02/2016
2	Messenger RNA (mRNA)IBA 02/2024 - 07/2007
2	SugarsIBA 02/2024 - 10/2022
2	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 01/2023 - 01/2021
2	Phosphatidylcholines (Phosphatidylcholine)IBA 01/2023 - 01/2021
2	Nonesterified Fatty Acids (NEFA)IBA 01/2023 - 03/2007
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2019
2	Carnitine (L-Carnitine)FDA LinkGeneric 01/2022 - 01/2021
2	Interleukin-6 (Interleukin 6)IBA 01/2021 - 08/2006
2	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2021 - 07/2007
2	Amino Acid Transport System AIBA 01/2021 - 01/2021
2	EnzymesIBA 01/2021 - 01/2017
2	Casein Kinase II (Casein Kinase 2)IBA 01/2020 - 04/2014
2	Ribosomal Proteins (Ribosomal Protein)IBA 01/2020 - 03/2014
2	Adiponectin ReceptorsIBA 01/2020 - 11/2019
2	Lactic Acid (Lactate)FDA LinkGeneric 01/2020 - 07/2006
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 10/2018 - 10/2015
2	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2018 - 01/2018
1	Ephrin-A3 (Ephrin A3)IBA 02/2024
1	EphrinsIBA 02/2024
1	EstersIBA 01/2023
1	phosphatidylethanolamineIBA 01/2023
1	HDL CholesterolIBA 01/2023
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2023
1	PlasmalogensIBA 01/2023
1	N 30IBA 01/2023
1	Docosahexaenoic AcidsIBA 01/2023
1	Glycerophospholipids (Phosphoglycerides)IBA 01/2023
1	CholesterolIBA 01/2023
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2023
1	Ether (Diethyl Ether)IBA 01/2023
1	RNA (Ribonucleic Acid)IBA 01/2023
1	Fibroblast Growth Factor 1 (FGF-1)IBA 11/2022
1	Dynactin ComplexIBA 11/2022
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 11/2022
1	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 01/2022
1	Pyruvic Acid (Pyruvate)IBA 01/2022
1	Oleic Acid (Oleate)IBA 01/2022
1	CarbohydratesIBA 01/2022
1	PPAR gammaIBA 01/2022
1	Pregnancy ProteinsIBA 01/2022
1	MicronutrientsIBA 01/2021
1	2,2-dimethyl-beta-alanineIBA 01/2021
1	acylcarnitineIBA 01/2021

Therapy/Procedure

2	Ligation 01/2020 - 01/2018